Seelos Therapeutics Inc (SEEL)

[jsbeach23]

I was just being cynical with the 'garbage comment'... without APRI mgmt providing clarity on Fispemifene and delivering better execution, the projections doesn't hold water if the earliest revenue estimates are in 2020 or 2024...

All the current 4 analysts following APRI are 'sell side', so they have some history with APRI, and either their relationship is sour, neutral, or optimistic for some new business, their views will be biased for the most part. That's why Cantor was overly optimistic with a buy target of $3, so they throw a bone and try to get more business, but now that APRI has done a deal with Aspire to sell stock, Cantor is kinda reprimanding APRI with a hold target of $1.50

Until we get real 'buy-side' analysts and more institutional ownership, these 4 analyst updates don't mean much for APRI PPS. Pascoe and BOD execution is what matters most, and we need to hold them accountable to delivering higher shareholder value QUICKLY!!! It's been over 19+ months since Pascoe has been CEO, and under his watch APRI PPS has lost nearly 50% value, despite all the catalysts that were lined up by previous CEO Damaj!